189 related articles for article (PubMed ID: 16444872)
21. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.
Maas R; Tan-Andreesen J; Schwedhelm E; Schulze F; Böger RH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):220-8. PubMed ID: 17296339
[TBL] [Abstract][Full Text] [Related]
22. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.
Li J; Wilson A; Gao X; Kuruba R; Liu Y; Poloyac S; Pitt B; Xie W; Li S
J Pharmacol Exp Ther; 2009 Oct; 331(1):234-43. PubMed ID: 19605523
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
24. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Desai A; Zhao Y; Warren JS
Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of asymmetric dimethylarginine.
Siroen MP; Teerlink T; Nijveldt RJ; Prins HA; Richir MC; van Leeuwen PA
Annu Rev Nutr; 2006; 26():203-28. PubMed ID: 16848705
[TBL] [Abstract][Full Text] [Related]
26. Changes in the arginine methylation of organ proteins during the development of diabetes mellitus.
Lee JH; Park GH; Lee YK; Park JH
Diabetes Res Clin Pract; 2011 Oct; 94(1):111-8. PubMed ID: 21855157
[TBL] [Abstract][Full Text] [Related]
27. [The role of asymmetric dimethylarginine in the regulation of nitric oxide level in rats with acute renal injury].
Sukhovershin RA; Gilinskiĭ MA
Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):497-505. PubMed ID: 22834339
[TBL] [Abstract][Full Text] [Related]
28. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
[TBL] [Abstract][Full Text] [Related]
29. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
[TBL] [Abstract][Full Text] [Related]
30. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
Bai Y; Hui R
Med Hypotheses; 2008; 70(5):962-6. PubMed ID: 17983707
[TBL] [Abstract][Full Text] [Related]
31. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).
Nijveldt RJ; Teerlink T; Siroen MP; van Lambalgen AA; Rauwerda JA; van Leeuwen PA
Clin Nutr; 2003 Feb; 22(1):17-22. PubMed ID: 12553945
[TBL] [Abstract][Full Text] [Related]
32. Asymmetric dimethylarginine and critical illness.
Brinkmann SJ; de Boer MC; Buijs N; van Leeuwen PA
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):90-7. PubMed ID: 24281375
[TBL] [Abstract][Full Text] [Related]
33. MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters.
Di Pasqua LG; Berardo C; Rizzo V; Richelmi P; Croce AC; Vairetti M; Ferrigno A
Mol Cell Biochem; 2016 Aug; 419(1-2):147-55. PubMed ID: 27357826
[TBL] [Abstract][Full Text] [Related]
34. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
Visser M; Paulus WJ; Vermeulen MA; Richir MC; Davids M; Wisselink W; de Mol BA; van Leeuwen PA
Eur J Heart Fail; 2010 Dec; 12(12):1274-81. PubMed ID: 20923854
[TBL] [Abstract][Full Text] [Related]
35. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
Shibata R; Ueda S; Yamagishi S; Kaida Y; Matsumoto Y; Fukami K; Hayashida A; Matsuoka H; Kato S; Kimoto M; Okuda S
Nephrol Dial Transplant; 2009 Apr; 24(4):1162-9. PubMed ID: 19015171
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
Selley ML
J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
[TBL] [Abstract][Full Text] [Related]
37. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
[TBL] [Abstract][Full Text] [Related]
38. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
Ferrigno A; Di Pasqua LG; Berardo C; Siciliano V; Rizzo V; Adorini L; Richelmi P; Vairetti M
PLoS One; 2018; 13(1):e0191430. PubMed ID: 29346429
[TBL] [Abstract][Full Text] [Related]
39. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
Böger RH; Bode-Böger SM
Semin Thromb Hemost; 2000; 26(5):539-45. PubMed ID: 11129410
[TBL] [Abstract][Full Text] [Related]
40. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.
Chobanyan-Jürgens K; Fuchs AJ; Tsikas D; Kanzelmeyer N; Das AM; Illsinger S; Vaske B; Jordan J; Lücke T
Amino Acids; 2012 Aug; 43(2):805-11. PubMed ID: 22075968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
